EPS Bio Technology Corp. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 142.993 million compared to TWD 120.117 million a year ago. Operating income was TWD 19.308 million compared to TWD 3.985 million a year ago. Net income was TWD 13.979 million compared to TWD 4.991 million a year ago. Basic earnings per share was TWD 0.59 compared to TWD 0.21 a year ago. For the half year, sales was TWD 250.039 million compared to TWD 220.020 million a year ago. Operating income was TWD 24.430 million compared to TWD 8.411 million a year ago. Net income was TWD 18.265 million compared to TWD 8.499 million a year ago. Basic earnings per share was TWD 0.77 compared to TWD 0.36 a year ago. Diluted earnings per share was TWD 0.76 compared to TWD 0.36 a year ago.